PARP-1 is involved in autophagy induced by DNA damage

José Antonio Muñoz-Gámez1, José Manuel Rodríguez-Vargas, Rosa Quiles-Pérez

  • 1Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd) and Laboratory of Medical Research, Academical Hospital San Cecilio, Granada, Spain.

Autophagy
|November 13, 2008
PubMed

Insights

Poly(ADP-ribose) polymerase-1 (PARP-1) activation is crucial for initiating autophagy, a protective cellular process, in response to DNA damage from chemotherapy. PARP-1 deficiency prevents this protective autophagy, leading to increased cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Autophagy is a cellular degradation process often activated in cancer cells during chemotherapy or radiation treatment.
  • Poly(ADP-ribose) polymerase-1 (PARP-1) inhibition enhances chemotherapy-induced cell death, but its role in DNA damage-induced autophagy remains unclear.

Purpose of the Study:

  • To investigate the role of PARP-1 in the cellular decision to undergo autophagy following DNA damage.
  • To determine if PARP-1 activation is necessary for doxorubicin-induced autophagy.

Main Methods:

  • Treatment of PARP-1 wild-type and deficient cells with doxorubicin.
  • Analysis of autophagic vesicles via electron microscopy and GFP-LC3 transfection.
  • Gene expression analysis of autophagy-related genes (bnip-3, cathepsin b and l, beclin-1).
  • Assessment of ATP/NAD+ levels and mTOR activation.

Main Results:

  • Doxorubicin treatment induced autophagic vesicles and increased autophagy gene expression in wild-type cells, but not in PARP-1 deficient cells or cells treated with a PARP inhibitor.
  • Lack of autophagy in PARP-1 deficient/inhibited cells was linked to prevention of ATP/NAD+ depletion and mTOR activation.
  • Inhibition of doxorubicin-induced autophagy led to increased cell death, indicating a protective role for autophagy.

Conclusions:

  • PARP-1 activation is involved in the cellular decision to initiate autophagy in response to DNA damage.
  • Doxorubicin-induced autophagy appears to be a cytoprotective mechanism against DNA damage.
  • Targeting PARP-1 may influence the efficacy of chemotherapy by modulating autophagy.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...